Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow HCW Biologics Inc.

Get SEC filing alerts via email and in your feed for HCW Biologics Inc.

HCWB

HCW Biologics Inc.

About HCW Biologics Inc.

HCW Biologics Inc. is a clinical-stage biopharmaceutical company developing proprietary immunotherapies targeting age-related and chronic inflammatory diseases, including cancer, autoimmune, and neurodegenerative conditions. Utilizing innovative platforms like TOBI and TRBC, it creates multi-functional fusion proteins and immune cell engagers to modulate immune responses. The company focuses on immunotherapies that reduce senescent cells and inflammation, aiming to extend health span and improve quality of life.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from HCW Biologics Inc.

1
1
HCW Biologics Inc. HCW Biologics Reports $6.5M Revenue and $3.5M Net Income in Latest Quarter

Via official filing (AI summary) | 20 days ago | 0 comments

2
1
HCW Biologics Inc. HCW Biologics Reports $7.96 Million Net Loss for 2025, Revenue Drops to $54,232

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
HCW Biologics Inc. HCW Biologics Reports Significant Revenue Decline and Ongoing Financial Challenges

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
HCW Biologics Inc. HCW Biologics Reports Revenue Decline and Financial Challenges in Latest 10-Q Filing

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
HCW Biologics Inc. HCW Biologics Reports Revenue Decline to $5,065 in Q1 2025, Net Loss Reduces to $2.2 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
HCW Biologics Inc. HCW Biologics Reports $30M Net Loss and Decreased Revenue for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
HCW Biologics Inc. HCW Biologics Reports Mixed Financial Results, Raises Concerns Over Going Concern

Via official filing (AI summary) | over 1 year ago | 0 comments